Bone-targeting Polymer Vesicles for Simultaneous Imaging and Effective Malignant Bone Tumor Treatment.

Xue Zhou,Ning Yan,Erik J. Cornel,Haidong Cai,Shaobo Xue,Hao Xi,Zhen Fan,Shisheng He,Jianzhong Du
DOI: https://doi.org/10.1016/j.biomaterials.2020.120345
IF: 14
2021-01-01
Biomaterials
Abstract:We present a bone-targeting polymer vesicle with excellent single photon emission computed tomography/computed tomography (SPECT/CT) imaging capability and high antitumor drug delivery efficiency as an integrated platform for the simultaneous diagnosing and treatment of malignant bone tumors. This polymer vesicle can be self-assembled from poly(ε-caprolactone)67-b-poly[(L-glutamic acid)6-stat-(L-glutamic acid-alendronic acid)16] (PCL67-b-P[Glu6-stat-(Glu-ADA)16]), directly in water without the aid of a cosolvent. SPECT/CT dynamically tracked the drug distribution in the bone tumor rabbit models, and the tumor size was significantly reduced from >2.0 cm3 to <0.6 cm3 over 11 days. The pathological analysis demonstrated obvious necrosis and apoptosis of the tumor cells. Overall, this bone-targeting polymer vesicle provides us with a new platform for the combination of real-time diagnosis and therapy of malignant bone tumors.
What problem does this paper attempt to address?